Federal Register / Vol. 70, No. 197 / Thursday, October 13, 2005 / Notices 59779 

6, Memorial Drive and Wadsworth 

Street, Cambridge, MA. 

Status: This workshop will be open to 

the public. 

Engineering Workforce Issues and 

Engineering Education: What Are the 

Linkages? 

8:25 a.m. Welcome 

Warren M. Washington,* Chairman, 

National Science Board 

8:30 a.m. Panel 1: Aspirations for 

Engineering Education 

Opening Remarks—Daniel Hastings,* 

National Science Board 

National Academy of Engineering—

The Engineer of 2020, Phases I & II 

G. Wayne Clough,* National 

Science Board 

Data, trends, and outlooks—John A. 

Brighton,* Iowa State University 

NSF activities in engineering—Arden 

L. Bement,* National Science 

Foundation 

9:10 a.m. Group Discussion among 

Workshop Participants 

9:20 a.m. Questions and Comments 

from the Audience 

9:30 a.m. Panel 2: Engineering 

Education—Present and Future 

Moderator: Daniel Hastings, National 

Science Board 

Alice Agogino,* University of 

California, Berkeley; Richard 

Miller,* Olin College of 

Engineering; Linda Katehi,* Purdue 

University; Eli Fromm,* Drexel 

University; and Tom Magnanti,* 

MIT. 

10:30 a.m. Group Discussion among 

Workshop Participants 

11:15 a.m. Questions and Comments 

from the Audience 

11:30 a.m. Break 

1 p.m. Panel 3: Engineering 

Employment—Present and Future 

Moderator: Louis L. Lanzerotti, 

National Science Board 

Peter Pao;* Raytheon Company; Ronil 

Hira,* IEEE–USA; Jim Miller,* 

Cisco Systems, Inc.; and Gloria 

Jeff,* Michigan Department of 

Transportation. 

2 p.m. Group Discussion among 

Workshop Participants 

2:45 p.m. Questions and Comments 

from the Audience 

3 p.m. Breakout Sessions to Address 

the Question: How do we ensure 

that the best and the brightest 

students pursue engineering studies 

and careers, and that their 

education quality, content, and 

teaching are of the highest caliber? 

Location: Dining 3, Dining 5, and 

Dining 6 

Session Chairs: G. Wayne Clough, 

Louis L. Lanzerotti, Daniel Hastings 

4:30 p.m. Report Out and Wrap-Up 

Moderator: Daniel Hastings* 

*Confirmed speaker 

For Further Information Contact: Dr. 

Michael P. Crosby, Executive Officer 

and NSB Office Director, (703) 292–

7000, http://www.nsf.gov/nsb. 

Michael P. Crosby, 

Executive Officer and NSB Office Director. 

[FR Doc. 05–20554 Filed 10–12–05; 8:45 am] 

BILLING CODE 7555–01–P 

NATIONAL SCIENCE FOUNDATION 

Sunshine Act; President’s Committee 

on the National Medal of Science; 

Notice of Meeting 

In accordance with the Federal 

Advisory Committee Act (Pub. L. 92–

463, as amended), the National Science 

Foundation announces the following 

meeting: 

NAME: President’s Committee on the 

National Medal of Science (1182). 

DATE AND TIME: Tuesday, October 25, 

2005, 8:30 a.m.–1:30 p.m. 

PLACE: Room 555–II, National Science 

Foundation, 4201 Wilson Blvd, 

Arlington, VA. 

TYPE OF MEETING: Closed. 

CONTACT PERSON: Ms. Ann Noonan, 

Honorary Awards Specialist, Room 

1220, National Science Foundation, 

4201 Wilson Blvd, Arlington, VA 22230. 

Telephone: 703–292–8096. 

PURPOSE OF MEETING: To provide advice 

and recommendations to the President 

in the selection of the 2005 National 

Medal of Science recipients. 

AGENDA: To review and evaluate 

nominations as part of the selection 

process for awards. 

REASON FOR CLOSING: The nominations 

being reviewed include information of a 

personal nature where disclosure would 

constitute unwarranted invasions of 

personal privacy. These matters are 

exempt under 5 U.S.C. 552b(c)(6) of the 

Government in the Sunshine Act. 

Dated: October 11, 2005. 

Susanne Bolton, 

Committee Management Officer. 

[FR Doc. 05–20648 Filed 10–11–05; 3:47 pm] 

BILLING CODE 7555–01–M 

NUCLEAR REGULATORY 

COMMISSION 

[Docket No. 030–35882] 

Notice of Availability of Environmental 

Assessment and Finding of No 

Significant Impact for License 

Amendment for Purdue Pharma, L.P.’s 

Facility in Cranbury, NJ 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Notice of availability. 

FOR FURTHER INFORMATION CONTACT: 

Betsy Ullrich, Commercial and R&D 

Branch, Division of Nuclear Materials 

Safety, Region I, 475 Allendale Road, 

King of Prussia, Pennsylvania 19406, 

telephone (610) 337–5040, fax (610) 

337–5269; or by e-mail: exu@nrc.gov. 

SUPPLEMENTARY INFORMATION: 

I. Introduction 

The Nuclear Regulatory Commission 

(NRC) is considering issuing a license 

amendment to Purdue Pharma, L.P. for 

Materials License No. 29–30698–01, to 

authorize release of its facility in 

Edgewater, New Jersey, for unrestricted 

use. NRC has prepared an 

Environmental Assessment (EA) in 

support of this action in accordance 

with the requirements of 10 CFR part 

51. Based on the EA, the NRC has 

concluded that a Finding of No 

Significant Impact (FONSI) is 

appropriate. 

II. EA Summary 

The purpose of the proposed action is 

to authorize the release of two sections 

of the licensee’s Cranbury, New Jersey, 

facility for unrestricted use. Purdue 

Pharma, L.P. was authorized by NRC 

from 2002 to use radioactive materials 

for research and development purposes 

at the site. On April 21, 2005, Purdue 

Pharma, L.P. requested that NRC release 

two sections of the facility for 

unrestricted use. Purdue Pharma, L.P. 

has conducted surveys of the two 

sections of the facility and provided 

information to the NRC to demonstrate 

that the site meets the license 

termination criteria in subpart E of 10 

CFR part 20 for unrestricted use. 

The NRC staff has prepared an EA in 

support of the license amendment. The 

two sections of the facility were 

remediated and surveyed prior to the 

licensee requesting the license 

amendment. The NRC staff has 

reviewed the information and final 

status survey submitted by Purdue 

Pharma, L.P. Based on its review, the 

staff has determined that there are no 

additional remediation activities